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SUMMARY 
The role of the protozoan parasite Toxoplasma gondii in the pathogenesis of liver disease has 
recently gained much interest. The aim of this study was to determine the prevalence and risk 
factors associated with T. gondii infection in patients with liver disease from three cities in 
Shandong and Henan provinces, China. A case-control study was conducted from December 
2014 to November 2015 and included 1142 patients with liver disease and 1142 healthy 
controls. Serum samples were collected from all individuals and were examined with enzyme-
linked immunosorbent assay for the presence of anti-T. gondii IgG and IgM antibodies. 
Information on the demographics, clinical and lifestyle characteristics of the participants was 
collected from the medical records and by the use of a questionnaire. The prevalence of anti-T. 
gondii IgG was 19.7% in patients with liver disease compared to 12.17% in the controls. Only 
13 patients had anti-T. gondii IgM antibodies compared to 12 control individuals (1.14% vs 
1.05%, respectively). The highest seroprevalence was detected in patients with liver cancer 
(22.13%), followed by hepatitis patients (20.86%), liver cirrhosis patients (20.42%), and 
steatosis patients (20%). Multivariate logistic regression analysis indicated that consumption of 
raw meat (odds ratio [OR] = 1.32; 95% CI, 1.01 to 1.71; P = 0.03) and source of drinking water 
from wells (odds ratio [OR] = 1.56; 95% CI, 1.08 to 2.27; P = 0.01) were independent risk 
factors for T. gondii infection in liver disease patients. These findings indicate that T. gondii 
infection is more likely to be present in patients with liver disease. Therefore, efforts should be 
directed toward health education of populations at high-risk of T. gondii infection and measures 
should be taken to protect vulnerable patients with liver disease. 
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INTRODUCTION 
Toxoplasmosis is a parasitic disease caused by infection with the intracellular apicomplexan 
protozoan parasite Toxoplasma gondii. This parasite has a worldwide distribution and is able 
to infect any warm-blooded animal [1]. Infections caused by T. gondii continue to impose a 
significant public health threat because it can cause hydrocephaly, retinochoroiditis, mental 
retardation, and even death in developing fetus and life-threatening encephalitis in organ 
transplant recipients, individuals with AIDS, or receiving immunosuppressive therapy [2–4]. T. 
gondii is one of the most successful protozoan parasites owing to its ability to manipulate the 
immune system and because of the various means (e.g. waterborne, foodborne, transplacental, 
or organ transplant) by which the parasite can infect the host and establish a latent infection [5–
9]. 
Although T. gondii possesses neurotropic and ocular affinities, this parasite can also infect 
other organs, such as liver, spleen, pancreas, heart, and lymph nodes [10, 11]. Several relatively 
small studies have detected association between T. gondii infection and various hepatic 
pathologies, such as hepatitis, granuloma, necrosis, hepatomegaly, jaundice, and cirrhosis [12–
18]. T. gondii infection has also been linked to abnormal liver function tests [19, 20]. Liver has 
been shown to be the major site of tissue pathology during acute, lethal toxoplasmosis in mice 
[21]. An association between the amount of T. gondii antigens and increased number of stellate 
cells (HSCs) has been reported in the liver of acutely infected mice, suggesting a role for HSCs 
in the pathogenesis of T. gondii-induced hepatitis [22]. Also, T. gondii infection has been shown 
to induce several transcriptomic and proteomic changes in the liver of infected mice [23, 24].  
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In recent years, interest in assessing and understanding the relationship between T. gondii 
infection and liver disease in humans has surged [25, 26], probably due to the huge global 
burden and public health importance of both T. gondii infection [27] and liver diseases [28]. As 
considerable results exist linking T. gondii infection to hepatic damage, and there is no available 
data about the correlation between liver disease and T. gondii infection in China, it is important 
to identify any evidence linking T. gondii infection to liver disease in humans in China. 
Therefore, the present study was conducted to investigate the seroprevalence of and risk factors 
associated with T. gondii infection in patients with liver disease from three major cities in 
Shandong and Henan provinces in eastern China using ELISA. Our study advances the 
literature of the association between liver disease and T. gondii infection. 
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MATERIALS AND METHODS 
 
Ethics statement 
The protocol of the study was reviewed and approved by the Ethics Committee of the Medical 
College of Qingdao University, Wenhaiwei People’s Hospital and Henan Provincial People’s 
Hospital. Patients were informed about the aim of the study, and they all provided written 
consent for participation in the study. Also, informed consent was provided by parents or 
guardians on behalf of all child participants. The control sera were collected with agreement 
from volunteers. 
 
Study sites 
The study was conducted in two provinces (Shandong and Henan) located in eastern China 
(Figure 1). Two cities were selected in Shandong province, namely Qingdao and Weihai. 
Qingdao is located at the south-eastern tip of Shandong province, eastern China (35°35′–
37°09′N, 119°30′–121°00′E), and is a key economic center, famous for its cultural heritage and 
attractive scenery. Weihai is located at the eastern tip of Shandong province (36°41′–37°35′N, 
121°11′–122°42′E). The annual average temperature is 12°C and the average precipitation is 
over 800mm. Zhengzhou (31°23′–36°22′N, 110°21′–116°39′E) is the capital of Henan 
province, which has a subtropical semi-humid monsoon climate with a hot, humid and rainy 
summer, long and cold winter, and an annual average temperature of 14°C. 
 
Study design and data collection  
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A case-control study was designed to identify prevalence and risk factors associated with T. 
gondii infection. The study was conducted from December 2014 to November 2015 and 
included 1142 inpatients hospitalized for the diagnosis or treatment of liver disease. The clinical 
cases included patients with various forms of hepatic disease, including liver cirrhosis (n = 
333), hepatitis (n = 326), liver cancer (n = 253), steatosis (n = 205), and other hepatic disease 
(n = 25). An equivalent number of seronegative control subjects (n = 1142), of similar age and 
gender from each of the three geographic regions were included in the study. Demographics, 
such as age, gender and area of residence were obtained from the computerized inpatient 
registry of cases or by asking the control participants. A questionnaire was distributed to all 
participants and to the parents of children or to adult individuals in order to obtain information 
about their lifestyle and feeding habits, including the history of close contact with cats or dogs 
at home (Yes/No), consumption of raw vegetables (Yes/No), exposure to soil (Yes/No), 
consumption of raw/undercooked meat (Yes/No), and the source of drinking water (None, 
running water, wells). All personal information was anonymized and treated as strictly 
confidential. 
 
Serum collection and serological testing  
Around 5-mL of venous blood were drawn from each participant. Blood samples were kept 
overnight at ambient temperature in order to allow clot formation and were centrifuged at 1000g 
for 10min. The sera were collected in 2-mL Eppendorf tubes and were stored at 4°C for 24–
72h until transportation in an icebox to State Key Laboratory of Veterinary Etiological Biology, 
Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Gansu 
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Province, where samples were kept at -20°C until analysis. Serum samples were analyzed for 
the presence of anti-T. gondii IgG and IgM antibodies (using commercially available ELISA 
kits (Demeditec Diagnostics GmbH, Germany) according to the manufacturer’s instructions. 
Positive and negative serum controls were included in every plate. 
 
Statistical analysis 
Comparison between cases and controls for continuous variables such as age used one-way 
ANOVA and are reported as mean ±S.D. For categorical variables, the Chi-square test or the 
Fisher's exact test was used and results are expressed either as percentage of total (number of 
cases or control) or median (IQR), as appropriate. To identify factors associated with T. gondii 
IgG seropositivity a univariate approach was first used with a cut-off of ≤ 0.10 to identify 
contributing factors to include in a multivariate analysis. Logistic regression was then used to 
identify significantly contributing factors with all variables included from univariate analyses.!
Only variables significant at p < 0.05 were retained in multivariate analysis. The statistical 
model included age and gender (fitted first, to account for minor variation in the datasets; 
adjustment used the Mantel-Haenszel test). All statistical analysis was performed using Genstat 
v18 (VSNi, Rothampsted, UK). Odds ratios (ORs) with 95% Confidence Intervals (CI) were 
calculated to indicate effect size of predictive variables. A P-value < 0.05 was considered to be 
statistically significant. 
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RESULTS 
Toxoplasma gondii IgG antibodies were detected in 225 (19.7%) of patients with liver disease, 
which was significantly higher (P < 0.001) than the level detected in the control individuals 
(139; 12.17%). In contrast, T. gondii IgM antibodies were only detected in 13 patients and 12 
controls (1.14% vs 1.05%, respectively, P = 0.84). Table 1 describes the seroprevalance 
according to patients’ age, gender, geographic region and residence area. The highest 
seroprevalence of T. gondii infection was found in patients with liver disease whose ages ranged 
from 41–50 (Table 1). The seroprevalence of T. gondii infection among patients with liver 
disease from rural areas (20.49%) versus urban areas (20.30%) was not significantly different 
(P = 0.71). 
 Association of T. gondii infection with clinical liver disease is shown in Table 2. Patients 
with liver disease had a higher frequency of T. gondii infection per se, with those patients with 
a diagnosis of liver cancer > cirrhosis > hepatitis having greatest seropositivity. Multivariate 
analysis revealed that consumption of raw meat (odds ratio [OR] = 1.32; 95% CI, 1.01 to 1.71; 
P = 0.03) and source of drinking water from wells (odds ratio [OR] = 1.56; 95% CI, 1.08 to 
2.27; P = 0.01) were the only independent risk factors for T. gondii infection in liver disease 
patients (Table 3). Other variables did not show any significant association with T. gondii 
infection. 
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DISCUSSION 
The present work revealed a higher prevalence of anti-T. gondii IgG antibodies in patients with 
liver disease compared with the control subjects (12.17%). It is possible that the immune-
compromised status associated with liver disease might make the patients become more 
vulnerable to infection with T. gondii compared to healthy individuals [29, 30]. One previous 
study did not detect an association between T. gondii infection and liver disease in patients from 
Mexico [26]. However, the prevalence rate obtained in our study was lower than that reported 
in Egypt in patients with hepatic disease 65.5% vs 27% in the controls [31], in late-stage 
cirrhotic patients 92.6% vs 15% controls, and chronic HCV non-cirrhotic patients 76.9% vs 
40% controls [32]. Another study in patients with chronic liver disease form Egypt reported 
30% vs 6% in controls [25]. Differences in prevalence rates among these studies could be 
attributed to geographic variability, heterogeneity of the studied populations or in the diagnostic 
approaches employed. In our study, the result of T. gondii IgM antibodies (1.14% vs 1.05%, 
respectively, P = 0.84) was not significantly different between cases and control. This finding 
is consistent with the results reported in patients with liver disease in Egypt where no significant 
difference (P = 0.610) in the level of anti-T. gondii IgM antibodies was detected in late stage 
(13.6%) and early stage (12.8%) patients compared to 7.5% controls [32].   
Recent transcriptomic [23] and proteomic [24] findings showed that T. gondii infection can 
dysregulate several signaling pathways especially immune response pathway in the liver of 
infected mice. Also, acute T. gondii can reduce the activity of hepatic enzyme 
butyrylcholinesterase, which plays a role in immune response and lipid synthesis [33]. 
Additionally, infection with T. gondii RH strain can elicit strong inflammatory response and 
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high levels of T helper cell type 1 (Th1) cytokines, which damage the liver [21]. Therefore, it 
is sensible to assume that the pathogenesis of liver damage during T. gondii infection can be 
induced by parasite-derived factors that disrupt host signaling pathways and/or host-mediated 
factors (and other as yet unknown mechanisms).  
Further, we found that patients with liver cancer had the highest T. gondii seroprevalence 
compared to other forms of liver diseases. This is expected because patients treated with 
antineoplastic agents are more likely to be infected with T. gondii [34, 35]. The immune-
suppression associated with chemotherapeutic treatment of patients with malignancies can 
result in the reactivation of latent T. gondii infection [36]. An association between T. 
gondii seropositivity and consumption of sheep meat in patients with live disease has been 
reported in Mexico (OR = 8.69; 95% CI: 1.02-73.71; P = 0.04) [26]. However, in our study 
none of the lifestyle variables, including contact with cats or dogs at home, consumption of raw 
vegetables, consumption of raw/undercooked meat, or exposure to soil, was found to have a 
significant association with T. gondii seropositivity. Interestingly, multivariate analysis 
revealed only two independent risk factors for T. gondii infection, which were the consumption 
of raw meat (odds ratio [OR] = 1.32; 95% CI, 1.01 to 1.71; P = 0.03) and source of drinking 
water from wells (odds ratio [OR] = 1.56; 95% CI, 1.08 to 2.27; P = 0.01).  
In China, cats are popular companion animals, but the public are not well-informed of the 
risk of environmental contamination with T. gondii oocysts [37]. Humans can be infected with 
T. gondii oocysts through drinking water contaminated with cat faeces [38], which has been 
identified as a public health threat [39]. Felids are the only definitive hosts for T. gondii, and 
primary infection results in shedding of millions of environmentally resistant non-sporulated 
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oocysts within approximately 2 weeks. Oocysts become infectious within 1–5 days, depending 
on the climatic conditions [40]. The identification of the source of drinking water as one of the 
two independent risk factors for T. gondii infection in our study necessitates that measures 
should be taken to protect the public in general and immunocompromised individuals in 
particular from the risk of water-borne infection with T. gondii oocysts. Likewise, the 
identification of consumption of raw meat as a significant risk factor for T. gondii infection 
confirms the overwhelming evidence regarding the epidemiological relevance of meat-borne 
infection with T. gondii [2, 4143]. There is a clear need for increased education of health 
professionals and the public about the potential transmission of T. gondii via drinking water 
from wells or consumption of raw meat in order to reduce the risk and burden of toxoplasmosis 
in China. 
 
CONCLUSION 
To our knowledge, this is the largest study that specifically investigates the epidemiology of T. 
gondii infection in association with liver disease. Additionally, our study examined patients 
with various clinical forms of liver disease and utilized multivariate analysis to determine which 
factors are independently associated with risk of T. gondii infection in patients with liver 
disease. Our results underscore the need for monitoring the presence of T. gondii infection in 
patients with liver disease especially those with immunocompromised status. Also, efficient 
lifestyle and environmental intervention strategies are needed in order to reduce the risk of 
water-borne and meat-borne transmission of T. gondii oocysts. Additional studies are needed 
to define which T. gondii genotype is most likely to be associated with hepathopathy in China. 
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Figure legend: 
 
Figure 1. Location maps of the study sites in eastern China showing the location of Qingdao, 
Weihai and Zhengzhou cities targeted in the present prevalence study. 
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Table 1. Demographics of the study population and seroprevalence of Toxoplasma gondii infection 
Variable 
Cases with liver diseases 
(n = 1142) 
Control group 
(n = 1142) 
P-value 
 No. tested No. positive Prevalence % No. tested No. positive Prevalence %  
Age group (years) 0.10 
  30 or less 103 23 22.33 254 40 15.75  
  31–40 153 29 18.95 169 16 9.47  
  41–50 309 74 23.95 297 38 12.79  
  51–60 243 38 15.64 150 13 8.67  
  61–70 190 36 18.95 132 17 12.88  
  70 144 33 22.92 140 26 18.57  
Gender 0.008 
  Male 595 114 19.16 532 67 12.59  
  Female 547 119 21.76 610 83 13.61  
Geographic region < .001   
  Qingdao 67395 87 22.03 382 44 11.52  
  Weihai 3439 95 27.22 494 67 13.56  
  Zhengzhou 398 51 12.81 266 39 14.66  
Residence area 0.71 
  Urban 532 108 20.30 649 66 10.17  
  Rural 610 125 20.49 493 84 17.04  
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Table 2. The seroprevalence of Toxoplasma gondii in patients with various hepatic disorders in China 
Clinical disease Patients with anti-T. gondii IgG antibodies 
No. tested No. positive (%) OR (95% CI) p-value 
None 1003 139 (13.8) reference - 
Liver cirrhosis 267 66 (24.7) 2.05 (1.46–2.86) < 0.001 
Hepatitis 259 67 (25.8) 1.85 (1.34–2.56) < 0.001 
Liver cancer 199 54 (27.1) 2.48 (1.69–3.65) < 0.001 
Steatosis 167 38 (22.7) 1.59 (1.06–3.39) 0.02 
Other 25 0 (0) - - 
Total 1920 364 (18.9) 1.91 (1.51–2.42) < 0.001 
* Include amoebic liver abscess, hepatic hemangioma, hepatic cyst, focal liver lesions and hepatocellular liver disease. 
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Table 3. Multivariate analysis of risk factors for Toxoplasma gondii infection in patients with liver disease  
 
 * OR, odds ratio; CI, 95% Confidence interval.  
1, Statistical model tested individual effect, after correction for Age, Gender and Geographic region.  
2, Statistical model excluded factors not-significant on univariate analysis, but included consumption of raw/undercooked meat and source of drinking water 
from wells, after correction for Age, Gender and Geographic region. 
 
 
  
Variable Number Number Prevalence Univariate analysis1  Multivariate analysis2 
tested positive % OR (95% CI) * p-value OR (95% CI) * p-value 
Cats at home 744 35 4.7 1.08 (0.77–1.51) 0.61 - - 
Dogs at home 744 29 3.9 1.13 (0.78–1.63) 0.49 - - 
Consumption of raw vegetables 744 73 9.81 0.90 (0.69–1.18) 0.48 - - 
Exposure to soil 744 97 13.04 1.13 (0.87–1.46) 0.34 - - 
Consumption of raw/undercooked meat 744 81 10.89 1.30 (1.00-1.69) 0.04 1.32 (1.01–1.71) 0.03 
Source of drinking water: None 
      Running water 
      Wells 
398 
587 
157 
48 
135 
42 
12.06 
23.0 
26.75 
Reference 
1.27 (0.95–1.68) 
1.79 (1.26–2.54) 
- 
0.09 
< .001 
- 
1.09 (0.79–1.50) 
1.56 (1.08–2.27) 
- 
0.56 
0.01 
